Marinus Pharmaceuticals Inc (MRNS)
1.52
0.00 (0.00%)
USD |
NASDAQ |
Jun 10, 16:00
1.52
0.00 (0.00%)
After-Hours: 19:49
Marinus Pharmaceuticals Gross Profit (Quarterly): 6.923M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.923M |
December 31, 2023 | 6.303M |
September 30, 2023 | 6.883M |
June 30, 2023 | 5.695M |
March 31, 2023 | 10.17M |
December 31, 2022 | 6.87M |
September 30, 2022 | 2.292M |
June 30, 2022 | 1.79M |
Date | Value |
---|---|
March 31, 2022 | 14.19M |
December 31, 2021 | 1.52M |
September 30, 2021 | 8.636M |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | 1.547M |
September 30, 2020 | 0.171M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.171M
Minimum
Sep 2020
14.19M
Maximum
Mar 2022
5.615M
Average
6.303M
Median
Dec 2023
Gross Profit (Quarterly) Benchmarks
Arcutis Biotherapeutics Inc | 46.31M |
Heron Therapeutics Inc | 26.23M |
Pfizer Inc | 11.50B |
ACADIA Pharmaceuticals Inc | 182.88M |
Actinium Pharmaceuticals Inc | -- |